Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, indicating a minor update to the study details page.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision tag on the page changed from v3.6.0 to v3.6.2, signaling a recent content update. This is a metadata/version update rather than a change to the substantive study information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now signals that recruitment has ended, and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also reformats the Intervention/Treatment heading and updates the revision version to v3.6.0.SummaryDifference0.4%

- Check29 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a software version update for the page. No impact on study data or user actions.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, reflecting a minor update to the page version.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s UI/release version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3” without changing the study details shown.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.